« Previous
Next »
Clinical Neurology and Neurosurgery
Volume 111, Issue 1
, Pages 79-82
, January 2009
Treatment of sialorrhea in children with Cerebral Palsy: A double-blind placebo controlled trial
References
- . A randomized trial of Botulinum toxin A for treatment of drooling. Neurology. 2003;61:1279–1281
- . Drooling and its management in cerebral palsy. Dev Med Child Neurol. 1987;29:807–811
- . Drooling in children with cerebral palsy. Acta-Oto-Rhino-Laryngol Belgica. 1980;34:691–705
- . Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr. 1998;37:485–490
- . Decreased drooling with oral motor stimulation in children with multiple disabilities. Am J Occup Ther. 1990;44:680–684
- . Experience with the Wilkie procedure for sialorrhea. Ann Otol Rhinol Laryngol. 1990;99(9 Pt 1):730–732
- . Submandibular duct relocation for drooling: a 10-year experience in 194 patients. Otolaryngol Head Neck Surg. 1989;101:87–92
- Botulinum toxin a as a treatment for excessive drooling in children. Pediatr Neurol. 2002;27:18–22
- . Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology. 2004;63:1371–1375
- . Clinical Study of Botulinum—A Toxin in the Treatment of Sialorrhea in Children with Cerebral Palsy. Laryngoscope. 2002;112:73–81
- . Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy Presentation of case series. Eur J Pediatr. 2001;160:509:512
- . Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3:73–78
- . Treatment of relative sialorrhea with Botulinum toxin type A: description and rationale for an injection procedure with case report. Eur J Neur. 2001;8:567–571
- . Human saliva: rate of flow of resting saliva of healthy individuals. Neurogastroenterol Motil. 1943;22:391–396
- . The parotid and submandibular secretion in man. Acta Otolaryngol. 1962;172:1–67(suppl)
- . Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy. Neurology. 2008;70:316–318
- . Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Dev Med Child Neurol. 2008;50:123–128
- . Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004;83(4):304–311
- . Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. 2004;114(3):620–627
- . Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006;48(11):883–887
- . Ultrasound-guided versus ‘blind’ intraparotid injections of Botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease. Clin Neuro Neurosurg. 2004;106:93–96
- . Botulinum toxin A as treatment for drooling saliva in PD. Neurology. 2000;54:244–247
PII: S0303-8467(08)00302-8
doi: 10.1016/j.clineuro.2008.09.001
© 2008 Elsevier B.V. All rights reserved.
« Previous
Next »
Clinical Neurology and Neurosurgery
Volume 111, Issue 1
, Pages 79-82
, January 2009
